Nutraceutical Ingredients Market - 2025-2033
The Nutraceutical Ingredients Market was valued at US$ 157.98 Billion in 2025 and is anticipated to reach by 2033, at a CAGR of 0.085 from 2026 to 2032.
The report delivers in-depth insights into key market dynamics, including regional growth trends, market segmentation, CAGR projections, and the revenue performance of leading industry players. It also highlights major growth drivers shaping the market landscape. Designed to provide a clear and comprehensive perspective, the report offers a detailed view of the current market size in terms of both value and volume, along with emerging opportunities and the overall development outlook of the Nutraceutical Ingredients Market.
This report delivers a comprehensive overview of the Nutraceutical Ingredients Market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Nutraceutical Ingredients Market. The Nutraceutical Ingredients Market size, estimates, and forecasts are provided in terms of output/shipments (K MT) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2025–2033.
Nutraceutical Ingredients Market Scope:
By Product Type
This report delivers a comprehensive overview of the Nutraceutical Ingredients Market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Nutraceutical Ingredients Market. The Nutraceutical Ingredients Market size, estimates, and forecasts are provided in terms of output/shipments (K Sqm) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2025–2033.
This report will assist keyword manufacturers, new entrants, and companies across the industry value chain with information on revenues, production, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Regional Analysis:
The report delivers in-depth insights into key market dynamics, including regional growth trends, market segmentation, CAGR projections, and the revenue performance of leading industry players. It also highlights major growth drivers shaping the market landscape. Designed to provide a clear and comprehensive perspective, the report offers a detailed view of the current market size in terms of both value and volume, along with emerging opportunities and the overall development outlook of the Nutraceutical Ingredients Market.
This report delivers a comprehensive overview of the Nutraceutical Ingredients Market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Nutraceutical Ingredients Market. The Nutraceutical Ingredients Market size, estimates, and forecasts are provided in terms of output/shipments (K MT) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2025–2033.
Nutraceutical Ingredients Market Scope:
By Product Type
- Probiotics
- Proteins and Amino Acids
- Phytochemical & Plant Extracts
- Fibers & Specialty Carbohydrates
- Omega-3 Fatty Acids
- Vitamins
- Prebiotic
- Carotenoids
- Minerals
- Others
- Dry
- Liquid
- Cognitive Health
- Gut Health
- Heart Health
- Bone Health
- Immunity
- Nutrition
- Weight Management
- Others
- Food
- ~Beverages
- Associated British Foods
- Arla Foods
- DSM
- Ingredients
- Tate & Lyle
- Ajinomoto
- CHR. Hansen
- Kyowa Hakko Kirin Group
- Glanbia Plc
- Fonterra Co-Operative Group Limited(LIST NOT EXHAUSTIVE)
This report delivers a comprehensive overview of the Nutraceutical Ingredients Market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Nutraceutical Ingredients Market. The Nutraceutical Ingredients Market size, estimates, and forecasts are provided in terms of output/shipments (K Sqm) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2025–2033.
This report will assist keyword manufacturers, new entrants, and companies across the industry value chain with information on revenues, production, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Regional Analysis:
- North America (U.S., Canada, Mexico)
- Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
- Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
- South America (Colombia, Brazil, Argentina, Rest of South America)
- Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)
- Increase Your Customer Base by 3X using our Partner Identification tool
- Uncover strategic collaboration opportunities with DataM vetted partners aligned to your ecosystem.
- Identify high potential M&A targets based on synergies, market positioning and growth trajectory.
- Prioritize partners by strategic fit rather than general capability.
- Data-Driven Insights: Dive into detailed analyses with granular insights such as pricing, market shares and value chain evaluations, enriched by interviews with industry leaders and disruptors.
- Post-Purchase Support and Expert Analyst Consultations: As a valued client, gain direct access to our expert analysts for personalized advice and strategic guidance, tailored to your specific needs and challenges.
- White Papers and Case Studies: Benefit quarterly from our in-depth studies related to your purchased titles, tailored to refine your operational and marketing strategies for maximum impact.
- Annual Updates on Purchased Reports: As an existing customer, enjoy the privilege of annual updates to your reports, ensuring you stay abreast of the latest market insights and technological advancements. Terms and conditions apply.
- Specialized Focus on Emerging Markets: DataM differentiates itself by delivering in-depth, specialized insights specifically for emerging markets, rather than offering generalized geographic overviews. This approach equips our clients with a nuanced understanding and actionable intelligence that are essential for navigating and succeeding in high-growth regions.
- Value of DataM Reports: Our reports offer specialized insights tailored to the latest trends and specific business inquiries. This personalized approach provides a deeper, strategic perspective, ensuring you receive the precise information necessary to make informed decisions. These insights complement and go beyond what is typically available in generic databases.
- Manufacturers/ Buyers
- Industry Investors/Investment Bankers
- Research Professionals
- Emerging Companies
1. METHODOLOGY AND SCOPE
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. DEFINITION AND OVERVIEW
3. EXECUTIVE SUMMARY
3.1. Market Snippet By Form
3.2. Market
3.3. Snippet By
3.4. Health BenefitsMarket Snippet By ApplicationMarket Snippet by Region
3.5. Market Snippet By Product Type
4. DYNAMICS
4.1. Impacting Factors
4.1.1. Drivers
4.1.1.1. Rise in the Launch of Nutraceutical Ingredient Products
4.1.1.2. Increase Awareness About Health Benefits of Nutraceutical Ingredients
4.1.2. Restraints
4.1.2.1. High Regulatory Stringent Laws Associated with Nutraceuticals
4.1.3. Opportunity
4.1.3.1. Innovations in Nutraceutical Ingredients Industry
4.1.4. Impact Analysis
5. INDUSTRY ANALYSIS
5.1. Porter’s 5 Forces Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
6. COVID-19 ANALYSIS
6.1. Analysis of COVID-19
6.1.1. Scenario Before COVID-19
6.1.2. Scenario During COVID-19
6.1.3. Scenario Post Covid-19
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion
7. BY PRODUCT TYPE
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
7.1.2. Market Attractiveness Index, By Product Type
7.2. Probiotics *
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Proteins and Amino Acids
7.4. Phytochemical & Plant Extracts
7.5. Fibers & Specialty Carbohydrates
7.6. Omega-3 Fatty Acids
7.7. Vitamins
7.8. Prebiotic
7.9. Carotenoids
7.10. Minerals
7.11. Others
8. BY FORM
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
8.1.2. Market Attractiveness Index, By Form
8.2. Dry *
8.2.1. Introduction
8.2.2. Market Size Analysis, US$ Billion, 2024-2033 and Y-o-Y Growth Analysis (%), 2026-2033
8.3. Liquid
9. BY HEALTH BENEFITS
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Health Benefits
9.1.2. Market Attractiveness Index, By Health Benefits
9.2. Cognitive Health *
9.2.1. Introduction
9.2.2. Market Size Analysis, US$ Billion, 2024-2033 and Y-o-Y Growth Analysis (%), 2026-2033
9.3. Gut Health
9.4. Heart Health
9.5. Bone Health
9.6. Immunity
9.7. Nutrition
9.8. Weight Management
9.9. Others
10. BY APPLICATION
10.1. Introduction
10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.1.2. Market Attractiveness Index, By Application
10.2. Food *
10.2.1. Introduction
10.2.2. Market Size Analysis, US$ Billion, 2024-2033 and Y-o-Y Growth Analysis (%), 2026-2033
10.2.3. Snacks
10.2.4. Confectionery
10.2.5. Bakery
10.2.6. Dairy
10.2.7. Meat & Meat Products
10.2.8. Baby Food
10.2.9. Others
10.3. ~Beverages
10.3.1. Energy Drinks
10.3.2. Juices
10.3.3. Health Drinks
10.3.4. Personal Care
10.3.5. Animal Nutrition
10.3.6. Dietary Supplement
11. BY REGION
11.1. Introduction
11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
11.1.2. Market Attractiveness Index, By Region
11.2. North America
11.2.1. Introduction
11.2.2. Key Region-Specific Dynamics
11.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
11.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
11.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Health Benefits
11.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
11.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
11.2.7.1. The U.S.
11.2.7.2. Canada
11.2.7.3. Mexico
11.3. Europe
11.3.1. Introduction
11.3.2. Key Region-Specific Dynamics
11.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
11.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
11.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Health Benefits
11.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
11.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
11.3.7.1. Germany
11.3.7.2. The U.K.
11.3.7.3. France
11.3.7.4. Spain
11.3.7.5. Italy
11.3.7.6. Rest of Europe
11.4. South America
11.4.1. Introduction
11.4.2. Key Region-Specific Dynamics
11.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
11.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
11.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Health Benefits
11.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
11.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
11.4.7.1. Brazil
11.4.7.2. Argentina
11.4.7.3. Rest of South America
11.5. Asia-Pacific
11.5.1. Introduction
11.5.2. Key Region-Specific Dynamics
11.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
11.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
11.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Health Benefits
11.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
11.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
11.5.7.1. China
11.5.7.2. India
11.5.7.3. Japan
11.5.7.4. Australia
11.5.7.5. Rest of Asia-Pacific
11.6. Middle East and Africa
11.6.1. Introduction
11.6.2. Key Region-Specific Dynamics
11.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
11.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
11.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Health Benefits
11.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
12. COMPETITIVE LANDSCAPE
12.1. Competitive Scenario
12.2. Market Positioning/Share Analysis
12.3. Mergers and Acquisitions Analysis
13. COMPANY PROFILES
13.1. Associated British Foods *
13.1.1. Company Overview
13.1.2. Product Portfolio and Description
13.1.3. Financial Overview
13.1.4. Key Developments
13.2. Arla Foods
13.3. DSM
13.4. Ingredients
13.5. Tate & Lyle
13.6. Ajinomoto
13.7. CHR. Hansen
13.8. Kyowa Hakko Kirin Group
13.9. Glanbia Plc
13.10. Fonterra Co-Operative Group Limited(*LIST NOT EXHAUSTIVE)
14. APPENDIX
14.1. About Us and Services
14.2. Contact Us
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. DEFINITION AND OVERVIEW
3. EXECUTIVE SUMMARY
3.1. Market Snippet By Form
3.2. Market
3.3. Snippet By
3.4. Health BenefitsMarket Snippet By ApplicationMarket Snippet by Region
3.5. Market Snippet By Product Type
4. DYNAMICS
4.1. Impacting Factors
4.1.1. Drivers
4.1.1.1. Rise in the Launch of Nutraceutical Ingredient Products
4.1.1.2. Increase Awareness About Health Benefits of Nutraceutical Ingredients
4.1.2. Restraints
4.1.2.1. High Regulatory Stringent Laws Associated with Nutraceuticals
4.1.3. Opportunity
4.1.3.1. Innovations in Nutraceutical Ingredients Industry
4.1.4. Impact Analysis
5. INDUSTRY ANALYSIS
5.1. Porter’s 5 Forces Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
6. COVID-19 ANALYSIS
6.1. Analysis of COVID-19
6.1.1. Scenario Before COVID-19
6.1.2. Scenario During COVID-19
6.1.3. Scenario Post Covid-19
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion
7. BY PRODUCT TYPE
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
7.1.2. Market Attractiveness Index, By Product Type
7.2. Probiotics *
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Proteins and Amino Acids
7.4. Phytochemical & Plant Extracts
7.5. Fibers & Specialty Carbohydrates
7.6. Omega-3 Fatty Acids
7.7. Vitamins
7.8. Prebiotic
7.9. Carotenoids
7.10. Minerals
7.11. Others
8. BY FORM
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
8.1.2. Market Attractiveness Index, By Form
8.2. Dry *
8.2.1. Introduction
8.2.2. Market Size Analysis, US$ Billion, 2024-2033 and Y-o-Y Growth Analysis (%), 2026-2033
8.3. Liquid
9. BY HEALTH BENEFITS
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Health Benefits
9.1.2. Market Attractiveness Index, By Health Benefits
9.2. Cognitive Health *
9.2.1. Introduction
9.2.2. Market Size Analysis, US$ Billion, 2024-2033 and Y-o-Y Growth Analysis (%), 2026-2033
9.3. Gut Health
9.4. Heart Health
9.5. Bone Health
9.6. Immunity
9.7. Nutrition
9.8. Weight Management
9.9. Others
10. BY APPLICATION
10.1. Introduction
10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.1.2. Market Attractiveness Index, By Application
10.2. Food *
10.2.1. Introduction
10.2.2. Market Size Analysis, US$ Billion, 2024-2033 and Y-o-Y Growth Analysis (%), 2026-2033
10.2.3. Snacks
10.2.4. Confectionery
10.2.5. Bakery
10.2.6. Dairy
10.2.7. Meat & Meat Products
10.2.8. Baby Food
10.2.9. Others
10.3. ~Beverages
10.3.1. Energy Drinks
10.3.2. Juices
10.3.3. Health Drinks
10.3.4. Personal Care
10.3.5. Animal Nutrition
10.3.6. Dietary Supplement
11. BY REGION
11.1. Introduction
11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
11.1.2. Market Attractiveness Index, By Region
11.2. North America
11.2.1. Introduction
11.2.2. Key Region-Specific Dynamics
11.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
11.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
11.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Health Benefits
11.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
11.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
11.2.7.1. The U.S.
11.2.7.2. Canada
11.2.7.3. Mexico
11.3. Europe
11.3.1. Introduction
11.3.2. Key Region-Specific Dynamics
11.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
11.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
11.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Health Benefits
11.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
11.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
11.3.7.1. Germany
11.3.7.2. The U.K.
11.3.7.3. France
11.3.7.4. Spain
11.3.7.5. Italy
11.3.7.6. Rest of Europe
11.4. South America
11.4.1. Introduction
11.4.2. Key Region-Specific Dynamics
11.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
11.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
11.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Health Benefits
11.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
11.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
11.4.7.1. Brazil
11.4.7.2. Argentina
11.4.7.3. Rest of South America
11.5. Asia-Pacific
11.5.1. Introduction
11.5.2. Key Region-Specific Dynamics
11.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
11.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
11.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Health Benefits
11.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
11.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
11.5.7.1. China
11.5.7.2. India
11.5.7.3. Japan
11.5.7.4. Australia
11.5.7.5. Rest of Asia-Pacific
11.6. Middle East and Africa
11.6.1. Introduction
11.6.2. Key Region-Specific Dynamics
11.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
11.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
11.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Health Benefits
11.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
12. COMPETITIVE LANDSCAPE
12.1. Competitive Scenario
12.2. Market Positioning/Share Analysis
12.3. Mergers and Acquisitions Analysis
13. COMPANY PROFILES
13.1. Associated British Foods *
13.1.1. Company Overview
13.1.2. Product Portfolio and Description
13.1.3. Financial Overview
13.1.4. Key Developments
13.2. Arla Foods
13.3. DSM
13.4. Ingredients
13.5. Tate & Lyle
13.6. Ajinomoto
13.7. CHR. Hansen
13.8. Kyowa Hakko Kirin Group
13.9. Glanbia Plc
13.10. Fonterra Co-Operative Group Limited(*LIST NOT EXHAUSTIVE)
14. APPENDIX
14.1. About Us and Services
14.2. Contact Us
